David Lewandowski | Director, Business Development, Cell and Gene Therapy
Brooks Life Sciences

David Lewandowski, Director, Business Development, Cell and Gene Therapy, Brooks Life Sciences

In his current role at Brooks, David visits with leading research, manufacturing and patient care facilities who require cryogenic infrastructure to support their efforts.  He recently completed his elected term as President for the International Society of Biological and Environmental Repositories (ISBER.org).  As President, he initiated an effort with the  Society of Cryobiology to create and publish the first Liquid Nitrogen-Based Storage Facility Best Practices.  This consensus document includes contributions from over 20 experts with a broad range of expertise.  David enjoys working with managers in supply chain, operations, facilities, QA/QC and others to define systems which are adaptable, scalable and repeatable.


Day 3: Friday 21st May 2021 - Commercialisation, Pricing & Access @ 14:30

Strategies, tech transfer & supply chain: challenges and scale up of product for patient delivery at cryogenic temperatures

last published: 10/May/21 08:45 GMT

back to speakers